Session Details
[S21]Structure-Membrane Permeability-Excretion Transporter Substrate Correlation Aimed at the Drug Discovery of Middle-Molecule Natural Product Derivatives."
Thu. Mar 27, 2025 5:00 PM - 6:30 PM JST
Thu. Mar 27, 2025 8:00 AM - 9:30 AM UTC
Thu. Mar 27, 2025 8:00 AM - 9:30 AM UTC
Room 14 (Fukuoka International Congress Center: 405+406 [4F])
Organizer: HIROYUKI MIYACHI (drug discovery initiative, Tokyo Univ.), KATSUMI MAENAKA (Facul. Pharm. Sci., Hokkaido Univ. / Grad. Sch. Pharm. Sci., Kyushu Univ.)
In recent years, middle molecules have garnered attention as a new modality in drug discovery. From the perspective of practical research aimed at drug development, it is crucial to consider not only the previously recognized challenges of middle molecules, such as poor cell membrane permeability (i.e., low membrane permeability coefficient), but also the control of efflux via transporters from inside to outside the cell. However, practical research and development that addresses both of these aspects has been largely lacking. Therefore, this symposium will focus on these dual perspectives. Presentations will be made by a highly heterogeneous group of researchers, including organic chemists, biochemist, computational chemist, and structural biologist. They will discuss the synthesis of various natural middle molecule derivatives such as bottromycins, macrocyclic peptides, and etoposide derivatives, as well as measurements of passive diffusion rates and cell membrane permeability. Additionally, molecular dynamics simulations predicting membrane permeability processes and cryo-electron microscopy analyses will be presented. Through these discussions, we aim to enhance understanding of the importance of comprehensively evaluating activity, membrane permeability, and P-glycoprotein substrate characteristics in the selection of candidate middle molecule for development.
趣旨説明:宮地 弘幸(東大院薬 創薬機構)
[S21-1]Synthesis of bottromycin derivatives to improve the membrane permeability and transporter substrate properties
○Masato Iwatsuki1,2, Tomoyasu Hirose1,2, Toshiaki Sunazuka1,2 (1. Grad. Sch. Infect. Cont. Sci., , Kitasato Univ., 2. Ōmura Satoshi Mem. Inst., Kitasato Univ.)
[S21-2]Study of the relationship between membrane permeability and three-dimensional structure of cyclopropane-based conformationally controlled cyclic peptides
○Mizuki Watanabe1, Yuki Yamazaki1, Yuta Takashima1, Satoshi Shuto1 (1. Fac. Pharm. Sci., Hokkaido Univ.)
[S21-3]Analysis of membrane permeation mechanism of cyclic peptides based on simulation of permeation process across lipid bilayer
○Masatake Sugita1,2 (1. Dept. of Computer Science, Science Tokyo, 2. MIDL, Science Tokyo)
[S21-4]Evaluation of whether middle molecules are substrates for P-gp using P-gp-overexpressing cells
○Hitoshi Kashiwagi1, Hayata Yamada2, Kenta Ojiya2, Yuki Sato1, Shunsuke Nashimoto1, Mizuki Watanabe1, Tomoyasu Hirose3,4, Masato Iwatsuki3,4, Toshiaki Sunazuka3,4, Kayoko Kanamitsu5, Mayumi Ishii5, Eri Watanabe5, Hiroyuki Miyachi5, Yoh Takekuma6, Mitsuru Sugawara1,6 (1. Fac. Pharm. Sci., Hokkaido Univ., 2. Sch. Pharm. Sci. Pharm., Hokkaido Univ., 3. Grad. Sch. Infect. Cont. Sci., Kitasato Univ., 4. Ōmura Satoshi Mem. Inst., Kitasato Univ., 5. Drug Discovery Initiative, Tokyo Univ., 6. Dept. Pharm., Hokkaido Univ. Hosp.)
[S21-5]Structural basis for P-gp substrate recognition for medium-sized molecules
○Takeshi Murata1 (1. Science/Chiba Univ.)